Control Patch News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Control Patch. Real-time updates on events, politics, business and more.

Birth Control Patch – How to Use, Advantages and Disadvantages

June 28, 2023

A birth control patch is a new method of contraception for women for once weekly external application and contains both estrogen and progesterone.

United States Simi Paknikar Nidhi Jain Alessandra Graziottin Williama Fisher Near Khuda Bukax Khan Library

Source: medindia.net

Candesant Biomedical Announces $35M in Series B Financing to Advance Commercialization of Brella™, the First and Only FDA-cleared 3-Minute SweatControl Patch™

June 6, 2023

/PRNewswire/ -- Candesant Biomedical, Inc. ("Candesant"), a private medical device company focused on the development and commercialization of non-invasive...

United States Suzanne Haber Candesant Biomedical Inc Prnewswire Candesant Biomedical Inc Brella Early Experience Program Consumer Survey On Cosmetic Dermatologic Procedures

Source: prnewswire.com

Candesant Biomedical Receives FDA Clearance of Brella™¹, the First and Only 3-Minute SweatControl Patch™, to Significantly Reduce Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)

April 13, 2023

/PRNewswire/ -- Candesant Biomedical ("Candesant"), a private medical device company focused on the development and commercialization of non-invasive...

New Orleans United States Suzanne Haber Dee Anna Glaser Candesant Biomedical Inc Consumer Survey On Cosmetic Dermatologic Procedures

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Control Patch News Today

Birth Control Patch &#x2013; How to Use, Advantages and Disadvantages

Candesant Biomedical Announces $35M in Series B Financing to Advance Commercialization of Brella&#x2122;, the First and Only FDA-cleared 3-Minute SweatControl Patch&#x2122;

Candesant Biomedical Receives FDA Clearance of Brella&#x2122;&#xB9;, the First and Only 3-Minute SweatControl Patch&#x2122;, to Significantly Reduce Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)

Explore More Categories

Birth Control Patch – How to Use, Advantages and Disadvantages

Candesant Biomedical Announces $35M in Series B Financing to Advance Commercialization of Brella™, the First and Only FDA-cleared 3-Minute SweatControl Patch™

Candesant Biomedical Receives FDA Clearance of Brella™¹, the First and Only 3-Minute SweatControl Patch™, to Significantly Reduce Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)